Artha Sootra - Company Dashboard

Governance Classic Home

Sudeep Pharma LtdPharmaceuticalsINE0QPI01025Consolidated₹1120.60+20.35 (+1.85%)

Valuation

Market Cap₹12.61K Cr

TTM PE66.27x

Forward PE66.68x

PEG27.96

Book Value₹84.76

P/B13.18x

TTM EPS₹16.85

Fwd EPS₹16.75

TTM Revenue₹709.65 Cr

TTM PAT₹188.64 Cr

TTM EBITDA₹250.71 Cr

TTM EBIT₹233.59 Cr

Last Qtr PAT₹51.81 Cr

Last Qtr EBITDA₹73.24 Cr

Last Qtr EBIT₹67.86 Cr

Profitability

ROE19.71%

ROCE22.56%

TTM NPM26.58%

TTM EBITDA %35.33%

Curr OPM25.56%

Last OPM24.79%

Curr NPM—

Last NPM—

Curr EPS₹4.59

Last EPS₹3.59

Balance sheet

Equity₹11.29 Cr

Reserve₹946.02 Cr

Total Debt₹187.68 Cr

D/E0.20x

Interest %5.42%

Curr Interest₹2.81 Cr

Price / range

Close₹1116.70

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+1.57%

1W+0.41%

1M-6.63%

3M+28.89%

6M+62.55%

1Y+53.96%

2Y—

3Y—

5Y—

Diwali+86.47%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1773.40	₹4.25L Cr	38.81	12.31%
DIVISLAB	10037.50	₹2.66L Cr	91.08	17.45%
TORNTPHARM	4738.50	₹1.60L Cr	77.77	11.42%
LAURUSLABS	2323.80	₹1.25L Cr	93.63	21.98%
ZYDUSLIFE	1188.10	₹1.20L Cr	28.53	15.79%
DRREDDY	1374.00	₹1.15L Cr	40.89	7.11%
CIPLA	1402.00	₹1.13L Cr	39.09	8.06%
MANKIND	2537.90	₹1.05L Cr	46.71	12.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	137.41+56.4%	105.68	80.17	90.28	87.88	338.51
Other Income	10.51	9.80	9.62	9.44	12.83	38.50
Total Income	147.92+46.9%	115.48	89.79	99.72	100.71	377.01
Interest	2.30	1.76	1.97	0.63	2.03	6.07
Expenditure	-91.15-49.9%	-70.08	-55.04	-63.10	-60.81	-231.91
PBDT	0	0	0	0	0	0
EBITDA	51.61+67.2%	39.19	28.89	29.61	30.87	119.78
Depreciation	-3.05	-1.83	-1.79	-1.80	-1.77	-7.11
EBIT	48.56+66.9%	37.36	27.10	27.81	29.10	112.67
PBT	56.77+42.3%	45.41	34.74	36.62	39.90	145.10
Tax	-14.43	-11.58	-8.98	-9.76	-10.16	-37.52
Equity	0	11.29	11.29	0	9.72	11.29
OPM	38.38	39.32	38.69	40.57	39.62	38.49
Net Profit	42.34+42.4%	33.83	25.77	26.87	29.74	107.58
NPM	28.62	29.30	28.70	29.76	29.53	28.54
EPS	3.74+40.1%	3	2.31	2.42	2.67	9.65

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26
Revenue	338.51
Other Income	38.50
Total Income	377.01
Expenditure	-231.91
Interest	-6.07
PBDT	0
EBITDA	119.78
Depreciation	-7.11
EBIT	112.67
PBT	145.10
Tax	-37.52
Equity	11.29
OPM (%)	38.49
Net Profit	107.58
NPM (%)	28.54
EPS (Rs)	9.65
CEPS	9.65

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	196.70+20.9%	158.27	182.34	172.34	162.67	642.26
Other Income	5.98	5.45	6.42	6.84	10.17	28.59
Total Income	202.68+17.3%	163.72	188.76	179.17	172.83	670.84
Interest	2.81	2.06	2.44	1.17	2.28	7.60
Expenditure	-131.65-16.2%	-109.42	-126.07	-117.40	-113.30	-442.77
PBDT	0	0	0	0	0	0
EBITDA	73.24+32.1%	54.91	62.59	59.97	55.46	221.90
Depreciation	-5.38	-4	-3.88	-3.86	-3.81	-14.81
EBIT	67.86+31.4%	50.91	58.71	56.11	51.65	207.09
PBT	71.03+19.3%	54.29	62.69	61.78	59.53	228.07
Tax	-19.22	-13.71	-14.15	-14.08	-12.76	-53.79
Equity	0	11.29	11.29	0	9.72	11.29
OPM	35.05	33.16	33.21	34.48	34.44	34.00
Net Profit	51.81+10.8%	40.59	48.54	47.70	46.78	174.28
NPM	25.56	24.79	25.72	26.62	27.07	25.98
EPS	4.59+9.3%	3.59	4.38	4.29	4.20	15.50

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26
Revenue	642.26
Other Income	28.59
Total Income	670.84
Expenditure	-442.77
Interest	-7.60
PBDT	0
EBITDA	221.90
Depreciation	-14.81
EBIT	207.09
PBT	228.07
Tax	-53.79
Equity	11.29
OPM (%)	34.00
Net Profit	174.28
NPM (%)	25.98
EPS (Rs)	15.50
CEPS	15.50

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	1.5	23 Jul 2026

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split